Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,617 | 352 | 81.0% |
| Travel and Lodging | $1,511 | 4 | 18.5% |
| Education | $42.00 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $3,732 | 86 | $0 (2024) |
| ABBVIE INC. | $1,280 | 77 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $882.94 | 55 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $360.08 | 35 | $0 (2024) |
| PFIZER INC. | $291.66 | 15 | $0 (2024) |
| Nevro Corp. | $244.31 | 10 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $209.75 | 12 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $196.03 | 13 | $0 (2022) |
| Horizon Therapeutics plc | $153.09 | 15 | $0 (2022) |
| Almatica Pharma LLC | $89.16 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,847 | 99 | Boston Scientific Corporation ($744.20) |
| 2023 | $1,725 | 80 | Boston Scientific Corporation ($622.83) |
| 2022 | $3,120 | 78 | Boston Scientific Corporation ($2,209) |
| 2021 | $1,477 | 101 | AbbVie Inc. ($252.74) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Opioid Analgesic | ||||||
| 12/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: OUD | ||||||
| 12/13/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/06/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/05/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/04/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: Opioid Analgesic | ||||||
| 11/25/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/21/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.05 | General |
| Category: Opioid Analgesic | ||||||
| 11/13/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: OUD | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $94.72 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/31/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.66 | General |
| Category: Opioid Analgesic | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: PAIN | ||||||
| 10/25/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $3.13 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/24/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/02/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.54 | General |
| Category: Opioid Analgesic | ||||||
| 09/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: PAIN | ||||||
| 09/25/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: WaveWriter Alpha_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 867 | 2,889 | $1.7M | $279,077 |
| 2022 | 7 | 896 | 3,140 | $1.9M | $309,195 |
| 2021 | 8 | 877 | 2,853 | $1.7M | $283,618 |
| 2020 | 9 | 1,390 | 3,169 | $1.4M | $255,948 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 319 | 1,869 | $1.1M | $155,547 | 13.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 175 | 343 | $305,270 | $66,806 | 21.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 210 | 492 | $137,760 | $29,963 | 21.8% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 149 | 164 | $114,800 | $25,167 | 21.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 14 | 21 | $12,240 | $1,594 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 340 | 1,979 | $1.2M | $159,424 | 13.0% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 218 | 510 | $453,900 | $100,209 | 22.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 230 | 533 | $149,209 | $32,739 | 21.9% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 30 | 31 | $34,410 | $7,511 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $31,980 | $3,827 | 12.0% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 22 | 22 | $15,400 | $3,410 | 22.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 17 | 26 | $14,670 | $2,074 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 348 | 1,853 | $1.1M | $159,434 | 14.1% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 211 | 426 | $373,345 | $84,663 | 22.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 225 | 440 | $121,309 | $27,342 | 22.5% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 30 | 37 | $25,678 | $5,794 | 22.6% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 19 | 34 | $19,136 | $2,684 | 14.0% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 14 | 33 | $10,176 | $1,420 | 14.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $8,808 | $1,302 | 14.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 19 | $7,062 | $979.31 | 13.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 436 | 1,429 | $674,489 | $102,698 | 15.2% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 230 | 368 | $292,560 | $72,787 | 24.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 307 | 769 | $250,612 | $37,902 | 15.1% |
| 80307 | Testing for presence of drug | Office | 2020 | 253 | 399 | $99,997 | $24,666 | 24.7% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 44 | 49 | $30,674 | $7,613 | 24.8% |
About Nathan Turner
Nathan Turner is a Physician Assistant healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2015. The National Provider Identifier (NPI) number assigned to this provider is 1508242595.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nathan Turner has received a total of $8,170 in payments from pharmaceutical and medical device companies, with $1,847 received in 2024. These payments were reported across 358 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,617).
As a Medicare-enrolled provider, Turner has provided services to 4,030 Medicare beneficiaries, totaling 12,051 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Annapolis, MD
- Active Since 08/03/2015
- Last Updated 08/03/2015
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1508242595
Products in Payments
- Spectra WaveWriter (Device) $2,077
- WaveWriter Alpha Prime 16 (Device) $1,465
- UBRELVY (Drug) $906.81
- NURTEC ODT (Drug) $678.52
- XTAMPZA (Drug) $442.12
- Belbuca (Drug) $440.82
- RELISTOR (Drug) $360.08
- QULIPTA (Drug) $359.35
- PENNSAID (Drug) $143.74
- Senza (Device) $127.89
- Omnia (Device) $116.42
- WAVEWRITER ALPHA (Device) $103.93
- Intracept (Device) $84.88
- BOTOX (Biological) $79.25
- Movantik (Drug) $76.92
- GRALISE (Drug) $72.41
- mild Device Kit (Device) $61.10
- AJOVY (Biological) $52.75
- SPECTRA WAVEWRITER (Device) $52.06
- Xeomin (Biological) $47.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Annapolis
Karen Scott, Pa, PA
Physician Assistant — Payments: $32,733
Lisa Fox, Pa C, PA C
Physician Assistant — Payments: $23,418
Andrew Marsella
Physician Assistant — Payments: $14,677
Julie Catlin, Pa-C, PA-C
Physician Assistant — Payments: $13,245
Ms. Melissa Veneracion, Pa-C, PA-C
Physician Assistant — Payments: $12,681
Sophia Leonard-Burns, Pa-C, PA-C
Physician Assistant — Payments: $5,895